EXTENZYN Trademark

Trademark Overview


On Monday, October 16, 2017, a trademark application was filed for EXTENZYN with the United States Patent and Trademark Office. The USPTO has given the EXTENZYN trademark a serial number of 87646716. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 5, 2021. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The EXTENZYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ...

General Information


Serial Number87646716
Word MarkEXTENZYN
Filing DateMonday, October 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2018
Attorney NameNOT AVAILABLE
Law Office Location CodeM70
Employee NameCROWLEY, SEAN MICHAEL
CorrespondentTeva Pharmaceuticals USA, Inc.
1090 Horsham Road
North Wales PA 19454

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address1090 Horsham Road
North Wales, PA 19454

Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1090 Horsham Road
North Wales, PA 19454

Trademark Events


Event DateEvent Description
Monday, April 5, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020EXTENSION 5 GRANTED
Thursday, August 20, 2020EXTENSION 5 FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020EXTENSION 4 GRANTED
Thursday, February 20, 2020EXTENSION 4 FILED
Thursday, February 20, 2020TEAS EXTENSION RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2019EXTENSION 3 GRANTED
Tuesday, August 20, 2019EXTENSION 3 FILED
Tuesday, August 20, 2019TEAS EXTENSION RECEIVED
Friday, February 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2019EXTENSION 2 GRANTED
Wednesday, February 20, 2019EXTENSION 2 FILED
Wednesday, February 20, 2019TEAS EXTENSION RECEIVED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018EXTENSION 1 GRANTED
Monday, August 20, 2018EXTENSION 1 FILED
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2017ASSIGNED TO LIE
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 9, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, November 9, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, November 3, 2017ASSIGNED TO EXAMINER
Wednesday, October 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 19, 2017NEW APPLICATION ENTERED IN TRAM